Literature DB >> 11452362

Familial chordoma, a tumor of notochordal remnants, is linked to chromosome 7q33.

M J Kelley1, J F Korczak, E Sheridan, X Yang, A M Goldstein, D M Parry.   

Abstract

Chordoma is a rare tumor originating from notochordal remnants that is usually diagnosed during midlife. We performed a genomewide analysis for linkage in a family with 10 individuals affected by chordoma. The maximum two-point LOD score based on only the affected individuals was 2.21, at recombination fraction 0, at marker D7S2195 on chromosome 7q. Combined analysis of additional members of this family (11 affected individuals) and of two unrelated families (one with 2 affected individuals and the other with 3 affected individuals), with 20 markers on 7q, showed a maximum two-point LOD score of 4.05 at marker D7S500. Multipoint analysis based on only the affected individuals gave a maximum LOD score of 4.78, with an approximate 2-LOD support interval from marker D7S512 to marker D7S684. Haplotype analysis of the three families showed a minimal disease-gene region from D7S512 to D7S684, a distance of 11.1 cM and approximately 7.1 Mb. No loss of heterozygosity was found at markers D7S1804, D7S1824, and D7S2195 in four tumor samples from affected family members. These results map a locus for familial chordoma to 7q33. Further analysis of this region, to identify this gene, is ongoing.

Entities:  

Mesh:

Year:  2001        PMID: 11452362      PMCID: PMC1235318          DOI: 10.1086/321982

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  16 in total

1.  Letter: Familial nasopharyngeal chordoma.

Authors:  W A Kerr; K L Allen; D R Haynes; S L Sellars
Journal:  S Afr Med J       Date:  1975-09-13

2.  Parametric and nonparametric linkage analysis: a unified multipoint approach.

Authors:  L Kruglyak; M J Daly; M P Reeve-Daly; E S Lander
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

3.  Identification of isochromosome 1q as a recurring chromosome aberration in skull base chordomas: a new marker for aggressive tumors?

Authors:  J R Sawyer; M Husain; O Al-Mefty
Journal:  Neurosurg Focus       Date:  2001-03-15       Impact factor: 4.047

4.  Clinical and pathologic review of 48 cases of chordoma.

Authors:  T A Rich; A Schiller; H D Suit; H J Mankin
Journal:  Cancer       Date:  1985-07-01       Impact factor: 6.860

5.  The investigation of linkage between a quantitative trait and a marker locus.

Authors:  J K Haseman; R C Elston
Journal:  Behav Genet       Date:  1972-03       Impact factor: 2.805

6.  A tumor suppressor locus in familial and sporadic chordoma maps to 1p36.

Authors:  M Miozzo; L Dalprà; P Riva; M Volontà; F Macciardi; S Pericotti; M G Tibiletti; M Cerati; K Rohde; L Larizza; A M Fuhrman Conti
Journal:  Int J Cancer       Date:  2000-07-01       Impact factor: 7.396

Review 7.  Chordoma: a critical review of diagnosis and treatment.

Authors:  J H Healey; J M Lane
Journal:  Orthop Clin North Am       Date:  1989-07       Impact factor: 2.472

8.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

Review 9.  Optimization of radiotherapy for patients with cranial chordoma. A review of dose-response ratios for photon techniques.

Authors:  P T Tai; P Craighead; F Bagdon
Journal:  Cancer       Date:  1995-02-01       Impact factor: 6.860

10.  The VITESSE algorithm for rapid exact multilocus linkage analysis via genotype set-recoding and fuzzy inheritance.

Authors:  J R O'Connell; D E Weeks
Journal:  Nat Genet       Date:  1995-12       Impact factor: 38.330

View more
  23 in total

1.  Clinical findings in families with chordoma with and without T gene duplications and in patients with sporadic chordoma reported to the Surveillance, Epidemiology, and End Results program.

Authors:  Dilys M Parry; Mary L McMaster; Norbert J Liebsch; Nicholas J Patronas; Martha M Quezado; Deborah Zametkin; Xiaohong R Yang; Alisa M Goldstein
Journal:  J Neurosurg       Date:  2020-06-19       Impact factor: 5.115

2.  The prognostic value of Ki-67, p53, epidermal growth factor receptor, 1p36, 9p21, 10q23, and 17p13 in skull base chordomas.

Authors:  Craig Horbinski; Gerard J Oakley; Kathleen Cieply; Geeta S Mantha; Marina N Nikiforova; Sanja Dacic; Raja R Seethala
Journal:  Arch Pathol Lab Med       Date:  2010-08       Impact factor: 5.534

3.  Familial chordoma: A case report and review of the literature.

Authors:  K E Wang; Zhen Wu; Kaibing Tian; Liang Wang; Shuyu Hao; Liwei Zhang; Junting Zhang
Journal:  Oncol Lett       Date:  2015-09-09       Impact factor: 2.967

4.  Gain of chromosome 7 by chromogenic in situ hybridization (CISH) in chordomas is correlated to c-MET expression.

Authors:  Beatriz A Walter; Maria Begnami; Vladimir A Valera; Mariarita Santi; Elisabeth J Rushing; Martha Quezado
Journal:  J Neurooncol       Date:  2010-07-10       Impact factor: 4.130

5.  Clinical features distinguish childhood chordoma associated with tuberous sclerosis complex (TSC) from chordoma in the general paediatric population.

Authors:  Mary L McMaster; Alisa M Goldstein; Dilys M Parry
Journal:  J Med Genet       Date:  2011-01-25       Impact factor: 6.318

6.  An integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordoma.

Authors:  Andrew C Nelson; Nischalan Pillay; Stephen Henderson; Nadège Presneau; Roberto Tirabosco; Dina Halai; Fitim Berisha; Paul Flicek; Derek L Stemple; Claudio D Stern; Fiona C Wardle; Adrienne M Flanagan
Journal:  J Pathol       Date:  2012-09-26       Impact factor: 7.996

7.  Update on the cytogenetics and molecular genetics of chordoma.

Authors:  Lidia Larizza; Pietro Mortini; Paola Riva
Journal:  Hered Cancer Clin Pract       Date:  2005-02-15       Impact factor: 2.857

8.  Case report: familial gastric cancer and chordoma in the same family.

Authors:  Walter Weber; Rodney J Scott
Journal:  Hered Cancer Clin Pract       Date:  2005-05-15       Impact factor: 2.857

9.  Aberrant hyperactivation of akt and Mammalian target of rapamycin complex 1 signaling in sporadic chordomas.

Authors:  Sangyeul Han; Carolyn Polizzano; Gunnlaugur P Nielsen; Francis J Hornicek; Andrew E Rosenberg; Vijaya Ramesh
Journal:  Clin Cancer Res       Date:  2009-03-10       Impact factor: 12.531

Review 10.  The molecular aspects of chordoma.

Authors:  Sukru Gulluoglu; Ozlem Turksoy; Aysegul Kuskucu; Ugur Ture; Omer Faruk Bayrak
Journal:  Neurosurg Rev       Date:  2015-09-12       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.